Form 4: DocuSign Executive Robert Chatwani Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
Robert Chatwani, President and General Manager of Growth at DocuSign, sold 14,799 shares of common stock at an average price of $55.46 on September 18, 2024, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On September 18, 2024, Robert Chatwani, President and General Manager of Growth at DocuSign, sold 14,799 shares of DocuSign (DOCU) common stock.
- The sale was executed at an average price of $55.46 per share, with individual prices ranging from $55.20 to $55.66.
- The transaction was conducted under a pre-arranged Rule 10b5-1 trading plan.
- Following the transaction, Chatwani directly owns 70,748 shares of DocuSign common stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the transaction is a routine sale under a pre-arranged plan. It doesn't necessarily indicate a positive or negative outlook for the company.
Positives
- The sale was conducted under a pre-arranged Rule 10b5-1 trading plan, which is a legal and transparent way for insiders to sell shares.
Risks
- Executive stock sales can sometimes be perceived negatively by investors, although sales under 10b5-1 plans are generally viewed as less concerning.
Industry Context
Executive stock sales are a common occurrence in publicly traded companies. Monitoring these transactions can provide insights into management's perspective on the company's valuation and future prospects. Sales under 10b5-1 plans are less likely to be driven by short-term market sentiment.
Comparison to Industry Standards
- Executive compensation packages often include stock options and grants, leading to periodic sales of shares.
- Companies like Adobe (ADBE) and Salesforce (CRM) also see regular Form 4 filings related to executive stock transactions.
- The use of 10b5-1 plans is a standard practice among executives to avoid accusations of insider trading.
Stakeholder Impact
- The stock sale may have a minor impact on shareholders, but the use of a 10b5-1 plan mitigates concerns about insider information.
Key Dates
| Date | Description |
|---|---|
| 09/18/2024 | Date of stock sale transaction |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.